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The American Journal of Pathology, the official journal of the American 
Society for Investigative Pathology (ASIP), seeks to publish high-quality original 
papers on the cellular and molecular biology of disease. The Editors accept 
manuscripts that advance basic and translational knowledge of the pathogenesis, 
classification, diagnosis, and mechanisms of disease, without preference for a 
specific analytic method. High priority is given to studies on human disease and 
relevant experimental models using cellular, molecular, animal, biological, 
chemical, and immunological approaches in conjunction with morphology.  
 
Manuscript Categories. Regular Articles are categorized in the Table of 
Contents according to the following research topics: Biomarkers, Genomics, 
Proteomics, and Gene Regulation; Biophysical Imaging and Computational 
Biology; Cardiovascular, Pulmonary and Renal Pathology; Cell Injury, Repair, 
Aging and Apoptosis; Epithelial and Mesenchymal Cell Biology; Gastrointestinal, 
Hepatobiliary and Pancreatic Pathology; Growth Factors, Cytokines, Cell Cycle 
Molecules; Immunopathology and Infectious Diseases; Matrix Pathobiology; 
Metabolic, Endocrine and Genitourinary Pathobiology; Molecular Pathogenesis of 
Genetic and Inherited Diseases; Musculoskeletal Pathology; Neurobiology; Stem 
Cells, Tissue Engineering and Hematopoietic Elements; Tumorigenesis and 
Neoplastic Progression; and Vascular Biology, Atherosclerosis and Endothelium 
Biology. Not all topic areas will appear in each issue, as this is dependent on the 
content of original research accepted for publication. Upon acceptance, authors will 
be asked for their preference of topic category assignment; however, the Editors 
will make the final determination regarding topic category placement. 
 
Short Communications are intended to provide a forum for the rapid publication 
of timely and significant findings, in brief. Manuscripts in this category should be 
concise but definitive, may be more descriptive and less mechanistic than Regular 
Articles, and must not exceed 12 double-spaced typed pages (excluding 
references and legends) and a maximum of 3 to 4 figures and tables. 
Categorization of manuscripts in this category is at the Editor’s discretion.  
 
In addition to original research articles, the Journal publishes articles categorized 
as Reviews, Mini-Reviews, Biolological Perspectives, and Commentaries. 
Authors who wish to publish a Review or Mini-Review should send their curriculum 
vitae along with an outline of the proposed article for prior approval by the Editor-in-
Chief. Reviews have a maximum of 6,000 words, 100 references, and 4 tables or 
figures (one of which is mechanistic); Mini-Reviews have a maximum of 4,000 
words, 50 references, and 2 tables or figures (one of which is mechanistic). 
Biological Perspectives are submitted by invitation only and provide streamlined, 
mechanistic insight into the current state of research in the discussed topic. 
Commentaries are submitted by invitation only and relate to a concurrently 
published manuscript. All invited papers are subject to the same review process as 
unsolicited articles.  
 
Review Process. The Editors perform an initial evaluation on all submissions to 
determine whether they believe the manuscript will achieve a sufficient priority 
score to warrant publication. Priority is determined by the Editors' assessment of 
the manuscript relative to other papers being considered. The aim is that 
expeditious treatment will enable authors to submit their manuscript elsewhere as 
soon as possible without suffering unnecessary delays. For manuscripts accepted 
for external review, the Editor-in-Chief assigns manuscripts to Associate Editors 
according to their expertise. The Associate Editor will solicit reviewers (typically, 
two external reviews are sought). Authors are encouraged to identify up to five 
potential reviewers. Authors may also request that specific reviewers not be used 
due to prior collaborations, known conflicts of interest, or direct competition. The 
Editors will make every effort to respect requests that are well-founded; however, 
the Editors do have the authority to utilize such a reviewer if it is necessary for 
expert peer review. It is the practice of the Journal to conduct a blinded peer-review 
process. The peer-review process is kept completely confidential; it is considered a 
violation of this confidentiality for authors to identify or attempt to communicate 
directly with peer reviewers or Associate Editors regarding their manuscript. The 
reviewer comments and Associate Editor's recommendation are evaluated by the 
Editor-in-Chief for disposition and transmittal to the authors. Every effort is made to 
complete the review process within 35 days of the date received. 
 
Review Decisions. Only a portion of manuscripts will be accepted for 
publication. A number of worthy manuscripts will be rejected based on priority. The 
Journal will advise authors whether the manuscript is accepted, acceptable with 
revisions, rejected but encourage resubmission (after major revision), or rejected. 
A manuscript may be returned to the authors without outside review if the Editors 
find it inappropriate for publication in this Journal. Appeals (rebuttals) to editorial 
decisions must be submitted within 60 days to be considered.  
 
Journal Scientific Integrity Policy. The Journal has developed principles for 
defining scientific misconduct as well as procedures for handling such matters. 
General guidelines are described below; detailed information can be viewed at 
http://www.journals.elsevierhealth.com/periodicals/ajpa/content/integrity. To report 
suspected misconduct relating to authors, reviewers, or Editors, send written 
complaint to the Editorial Office at The American Journal of Pathology, 9650 
Rockville Pike, Bethesda, Maryland, USA 20814-3993 or ajp@asip.org. Issues 
relating to staff conduct should be directed to the ASIP Executive Officer at 
American Society for Investigative Pathology, 9650 Rockville Pike, Bethesda, 
Maryland, USA 20814-3993 or mesobel@asip.org.  
 
Author Conduct. Authorship is defined as 1) substantial contributions to 
conception and design, or acquisition of data, or analysis and interpretation of data; 
2) drafting the manuscript or revising it critically for important intellectual content; 
and 3) final approval of the version to be published. Authors should meet 
conditions 1, 2, and 3. When submitting a manuscript to the Journal, the 
corresponding author takes responsibility on behalf of all authors for the 
authorship, authenticity, and integrity of the research being reported. Authors 
should take special care that manuscripts submitted to the Journal are prepared in 
accordance with the Uniform Requirements for Manuscripts Submitted to 
Biomedical Journals (see http://www.icmje.org); in particular the ethical 
considerations regarding authorship, conflicts of interest, redundant publication, 
and treatment and confidentiality of research subjects should be carefully adhered 
to. Additionally, the Journal takes great care to secure the confidentiality and 
integrity of the peer-review process; it is considered a violation of this confidentiality 
for authors to identify or attempt to communicate directly with peer reviewers or 
Associate Editors regarding their manuscript. The Editors will consider any 
deliberate ethical violation in either the reported research or the manuscript 
preparation and review to be actionable misconduct, the potential results of which 
may be manuscript rejection or public article retraction, reporting of conduct to the 
authors’ governing institutions, and/or the denial to consider any future 
submissions to the Journal. Willful misconduct does not include incidents of honest 
misjudgment or inadvertent error. Detailed information regarding possible 
misconduct can be found in the Journal Scientific Integrity Policy at 
http://www.journals.elsevierhealth.com/periodicals/ajpa/content/integrity. 
 
Manuscript Submission. Manuscripts should be submitted online via the 
Rapid Review system (http://www.rapidreview.com/ASIP2/CALogon.jsp). Detailed 
instructions on preparing and submitting files can be found on the author 
submission website at the above URL. Authors having difficulty submitting files 
online should complete the online submission form on Rapid Review to receive the 
assigned manuscript number. With the manuscript number clearly noted, electronic 
files (manuscript text, figures, and tables) should be emailed to the Editorial Office 
at ajp@asip.org or sent on disk by mail to: Michael P. Lisanti, M.D., Ph.D., Editor-
in-Chief, The American Journal of Pathology, 9650 Rockville Pike, Bethesda, 
Maryland, USA 20814-3993. The cover letter must state any conflicts of interest 
(both financial and personal), affirm that the manuscript has not been published 
previously and is not being considered concurrently by another publication, and 
affirm that all authors and acknowledged contributors have read and approved the 
manuscript. Submissions will be ineligible for review if previously published in any 
form (print or online) other than as an abstract. This includes any public posting of 
raw manuscripts or pre-reviewed material. 
 
A non-refundable manuscript processing fee of US$50 is required with submission. 
This fee should be paid electronically at the time of submission. Manuscripts 
arising from research in developing countries may be eligible for waiver of the 
submission fee only if all authors are located in a qualifying country (waiver must 
be applied for at time of submission; for a list of eligible countries, see Group A and 
Group B countries at http://www.who.int/hinari/eligibility/en). Otherwise, manuscript 
submission fees will not be waived. 
 
Manuscript Preparation. Manuscripts should be prepared in the style of the 
Journal and in accordance with The Uniform Requirements for Manuscripts 
Submitted to Biomedical Journals (see http://www.icmje.org). The preferred file 
format for text is MS Word. Standard abbreviations can be found in the CSE Style 
Manual (7th ed., 2006). All pages of the manuscript should be double-spaced and 
numbered (including references, tables and figure legends); line numbers should 
also be included to assist reviewers in making comments. Other formatting 
specifications (eg, font size and type, margin settings, etc) are left to the authors’ 
discretion, as papers accepted for publication will be reformatted according to the 
print specifications of the Journal. Manuscripts not prepared in accordance with the 
submission guidelines detailed below may be returned to the authors. Authors are 
encouraged to include a list of nonstandard abbreviations to aid reviewers; 
however, the Journal does not publish abbreviations or keywords as part of the 
final article. In addition, authors should be ready to comply with Editors’ requests 
for copies of any similar works in preparation, copies of cited manuscripts that are 
submitted or in press, and/or supporting manuscript data (eg, data not shown but 
summarized in the manuscript) that may aid the review process. 
 
Title Page. The title page must include a concise title accurately reflecting the 
findings of the work; full names (not initials) of all authors; department, institution 
and address where the research was performed; number of text pages, tables, and 
figures; a short running head (40 characters or less); grant numbers and sources 
of support; name, address, phone, fax, and email of the corresponding author; and 
name and address of author who should receive reprint requests if different from 
corresponding author. If an author changes employment after the study was 
performed, the new affiliation information for that author should be included as a 
footnote. Any relationships (eg, employment, consultancies, board membership, 
stock ownership, funding, honoraria, expert testimony, patents or royalties, travel 
reimbursements, industry-supplied free reagents, etc) with any organization or 
entity having a direct financial or personal interest in the subject matter or materials 
discussed in the article should also be clearly stated. 
 
Abstract. An abstract of 220 words or less should be prepared on a separate 
sheet and should be intelligible to the general reader without reference to the text. 
The abstract should clearly summarize the background, methodology, results, and 
significance of the study. Abbreviations and citations should be avoided. 
 
Text. The remaining sections of the text, which should include Introduction, 
Materials and Methods, Results, Discussion, and Acknowledgments (in this order), 
need not begin on new pages. Commonly-abbreviated terms should be spelled out 
in their first occurrence and then may be referenced in abbreviation through the 
remainder of the manuscript. The Journal requires the use of official gene and 
protein symbols, to facilitate standardization of scientific communication. Consult 
the Human Genome Organisation Gene Nomenclature Committee website 
(http://www.genenames.org/) for gene names and symbols and UniProt 
(http://www.uniprot.org) for protein names and symbols. For a complete list of other  
approved nomenclature organizations (eg, bacteria, viruses, mice), please contact 
the Editorial Office.  
 
For Materials and Methods, authors should describe experimental and statistical 
methods in enough detail that other researchers can replicate results and evaluate 
claims. In general, inclusion of method or reagent details as supplementary 
material is not acceptable. The sequences of oligonucleotides, if not previously 
published, should be provided. Novel DNA or protein sequences should be 
deposited to an appropriate database (eg, Genbank, EMBL, SWISS-PROT), with 
the accession numbers included in the manuscript. When providing supplier 
information for materials sources, company name and location (city and state, or 
city and country) should be provided. Website references to company information 
are not permitted. All novel materials and the procedures to prepare them should 
be described in sufficient detail to allow their reproduction (eg, DNA constructs, 
analytical software). Materials that are approved for investigational-use only should 
be clearly indicated. Publication in the Journal implies that the authors agree, upon 
reasonable request, to share any materials or data that are integral to the results 
presented in the article, including whatever would be necessary for a skilled 
investigator to verify or replicate the claims. Authors must disclose upon 
submission any restrictions on the availability of materials or information, such as for 
patented or dual-purpose materials.  
 
Reporting guidelines for specific study designs (eg, randomized controlled trials) 
can be found in the Uniform Requirements for Manuscripts Submitted to 
Biomedical Journals (see http://www.icmje.org). Authors must affirm that the 
research protocol was approved by the appropriate institutional review boards or 
ethics committees for human (including use of human cells or tissues) or animal 
experiments and that all human subjects provided appropriate informed consent 
and/or that regulations concerning the use of animals in research were adhered to. 
If race/ethnicity is reported, authors should state who determined race/ethnicity, 
how the options were defined, and why race/ethnicity was important in the study. 
Authors should be prepared to provide study protocol number(s) if requested. 
 
Authors should obtain permission from all individuals named (by full name) in the 
Acknowledgments who contributed substantially to the work reported (eg, data 
collection, analysis, or writing/editing assistance) but did not fulfill the authorship 
criteria. Likewise, authors should receive permission from all individuals named as 
sources for personal communication or unpublished data. Such permissions 
should be affirmed by the corresponding author in the cover letter. 
 
References. References should begin on a new page, be double-spaced and 
numbered in order of citation in the text, including citations in tables and figure 
legends. Complete author citation is required (use of "et al" is not acceptable). 
References should conform to the style of the Journal. Examples follow: 
 Journals: Cecena G, Wen F, Cardiff RD, Oshima RG: Differential sensitivity of 
mouse epithelial tissues to the polyomavirus middle T oncogene. Am J Pathol 
2006, 168:310-320 
 Books: Fishman AP: Pulmonary Hypertension and Cor Pulmonale. Pulmonary 
Diseases and Disorders. Edited by Fishman AP. New York, McGraw-Hill, 1988, pp. 
999-1048 
 In press: To be used only for papers accepted for publication. Cite as for journal 
with (in press) in place of volume and page numbers. Include digital object 
identifier (doi) when available for online early publications.  
 Submitted papers/unpublished data: Cite in text only.
 Web sites: Cite in text only. See Data Supplements section below for proper use 
of web site references. Use the doi when available. Include the name of the 
institution sponsoring the web site, URL address with direct linkage to the 
referenced information, and date of access. 
 
Tables. Tables should be typed double-spaced and submitted after the main text 
on separate pages, as part of the manuscript. The preferred file format for Tables 
is MS Word; figure file formats (including those embedded in the text) are 
unacceptable. Tables should be black and white text only and should not include 
figures or other non-typeset images. Color or gray shading is not permitted. 
Emphasis may be represented by bold, italics, and underlining. Table footnotes 
should use the following sequential symbols: *, †, ‡, §, ¶,Œ; these may be doubled 
up if needed. All symbols and abbreviations in the table should be defined in the 
footnotes.  
 
Figures. Authors should give considerable care in preparing figures. Resolution 
and quality of submitted images is the responsibility of the author; as a routine, the 
Journal does not provide figure enhancement services. Images (such as graphs 
and schematics) should have a white background; color, black, or gray is generally 
unacceptable. Authors are encouraged to carefully consider whether bar or line 
graphs should be submitted in grayscale or color, paying special attention to the 
ability of a reader to distinguish between different data points.  Figures may consist 
of multiple related panels (labeled A, B, C, etc) described under one figure legend. 
Each figure (with all of its related panels) should be arranged on a single page as it 
should appear in final publication. Figure labels should appear in the upper left 
corner as uppercase letters; refrain from using sub-labels (Aa, Ab, Ai, Aii, A1, A2, 
etc) or titles for each panel label; panels should be labeled chronologically from left 
to right. Figure panels submitted on separate pages will be arranged at the 
publisher's discretion. If figures are to be published in black and white, they should 
be submitted for review in black and white. Figures should be sized to fit one 
column (8 cm) or two columns (17 cm). Maximum page length is 22.5 cm. Figures 
deviating from these dimensions will be sized at the publisher's discretion. 
Unwanted background material should be excluded, and edges should be straight.  
 
 Preparation of Images (Ethics): Taking photographs of the same source under 
varied fields of view, light intensity, magnifications, or contrast conditions without 
disclosing that the data are not unique to the present study constitutes suspect 
scientific conduct. Further, unless serial sections are used, the publication of 
identical-appearing images labeled with different staining techniques in different 
papers raises legitimate questions. Finally, reuse of one’s data (ie, “self-
plagiarism”) is a copyright violation if the authors signed over copyright to the 
publisher; the reuse of such copyrighted images is at the sole discretion of the 
publisher, with proper attribution of the original publication a requirement of reuse. 
No specific feature within an image may be enhanced, obscured, moved, removed, 
or introduced. The grouping of images from different parts of the same gel or blot, 
or from different gels or blots, fields, or exposures must be made explicit by the 
arrangement of the figure (eg, using dividing lines) and in the figure legend. 
Adjustments of brightness, contrast, or color balance are acceptable only if they 
are applied to the whole image, whether experimental or control image, and as 
long as they do not obscure or eliminate any information present in the original 
(Portions adapted with permission from the JCB). Any evidence of inappropriate 
manipulation may prompt the Editors to request an explanation and access to 
original data, which the authors must make available. Information can be found in 
the Journal Scientific Integrity Policy at http://www.journals.elsevierhealth.com/ 
periodicals/ajpa/content/integrity.  
 
Digital Art: Digital figure files are required for submission. The American Journal 
of Pathology’s requirement for color images is RGB (Red, Green, Blue) color 
mode. Images submitted in RGB will retain the vivid reds, greens, and blues of the 
original digital files for online publication. Authors should therefore submit all 
figures (for both new and revised manuscripts) in the RGB color mode. The 
preferred file formats for digital figures are PDF, TIFF, and EPS. For detailed 
instruction on preparing digital art for submission or production, visit 
http://www.elsevier.com/wps/find/authorsview.authors/authorartworkinstructions or 
contact the Editorial Office (ajp@asip.org).  
 
Figure Legends. Figure legends should be submitted as part of the manuscript 
(separate from the figure files) and should describe any staining method and 
degree of magnification. If the exact scale is critical, scale bars should be used on 
the photograph and specified in the legend. Figure legends should adequately 
describe all descriptors: arrows, arrowheads, scale bars, insets, asterisks, 
boxes/circles/etc in line graphs, and any other notations. Descriptive text, rather 
than graphics inserted into the text, should be used when possible (eg, closed 
circles, open boxes, hatched bars, etc); alternatively, a legend key should be 
included in the figure. Statistical significance (eg, P values) should be clearly 
defined by asterisks (*, **, ***) or by other sequential symbols: *, †, ‡, §, ¶,Œ; these 
may be doubled up if needed. P values should be labeled by symbol in the image, 
with definitions appearing only in the legend. All abbreviations should also be 
defined.  
 
Data Supplements and Non-Traditional Media. Figures and tables that 
are critical to the evaluation and understanding of the research presented, but 
which cannot be accommodated via the print medium (eg, video), will be 
considered part of the manuscript submission and will be published on the Journal 
website if the manuscript is accepted. Supplemental figures, tables, and legends 
should be prepared as above. Supplemental material published on the Journal 
website is subject to the same copyright as applies to the printed article. Online 
data will remain associated with its article and is not subject to any modifications or 
updates after publication. Authors of accepted manuscripts will be charged $95 per 
supplemental data file to be published on the Journal website (up to 1MB; files over 
1MB will be charged an additional $95 per megabyte). Authors are therefore 
encouraged to minimize the size of their supplemental data files.  
 
Complex data sets such as microarray data and gene sequences should be 
deposited in a reliable public archive. Microarray repositories should comply with 
the Minimum Information About a Microarray Experiment (MIAME) guidelines 
(http://www.mged.org/Workgroups/MIAME/miame_1.1.html). Examples include 
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and Array Express 
(http://www.ebi.ac.uk/arrayexpress/). Tissue microarray data exchange specifications 
can be found at http://www.biomedcentral.com/1472-6947/3/5. Otherwise, the data 
may be published as supplemental data on the Journal=s website (http://ajp.amjpathol.org). 
 
Other materials that are not required to understand and evaluate the article may be 
stored on an institutional website and referenced as a URL within the manuscript 
text. In this case, the authors must assume responsibility for maintaining a live, 
unrestricted link to the material from the URL published within the article, in 
perpetuity. Failure to maintain a live, unrestricted link may result in retraction of the 
article by the Editors. Material that has been published previously (print or online) is 
not acceptable for posting as supplementary data. Instead, the appropriate 
reference(s) to the original publication should be made in the text and references.  
The Editors will make the final determination as to whether a given data set is 
essential to the manuscript and whether they will require publication of the material 
on the Journal website. Failure to relinquish required materials for online 
publication can result in the reversal of a manuscript’s acceptance.  
 
Copyright. Copyright of published manuscripts is held by the American Society 
for Investigative Pathology, which must receive the assignment of copyright from 
the authors of accepted manuscripts. For US government employees, the above 
assignment applies only to the extent allowable by law. For detail, see 
http://www.asip.org/pubs/ajprights.pdf. 
 
Publishing in The American Journal of Pathology automatically places authors in 
compliance with NIH Public Access Policy (see http://publicaccess.nih.gov 
/submit_process.htm, Submission Method A). Any article noted as being funded by 
NIH, HHMI, Wellcome Trust, or MRC is deposited in PubMed Central (PMC), to be 
made available to the public twelve months after final print publication (unless the 
funding agency stipulates a sooner release date). Authors therefore should NOT 
complete a separate deposit of their material but will be contacted by PubMed 
Central for grant verification once the article has been received by the PMC article 
system. For information on how to cite articles in NIH grant applications, please 
visit http://www.asip.org/pubs/AuthorNotice.cfm. 
 
Contact healthpermissions@elsevier.com regarding permission to deposit 
manuscripts in other government-sponsored repositories in cases where The
American Journal of Pathology does not have a system in place to automatically 
deposit materials on behalf of their authors. Deposit of accepted or published 
manuscripts in any non-AJP repository without prior permission by the Journal is a 
violation of copyright. 
 
Embargo Policy. All information regarding the content of submitted or accepted 
manuscripts is strictly confidential. Information contained in or about accepted 
articles cannot appear in print, audio, video, or digital form or be released by the 
news media until the Journal embargo date has passed, not to exceed the 
publication date of the article. For detailed information on embargo release dates 
or for news media requests for preprint copies of specific articles, contact 
asipproduction@elsevier.com. 
 
Financial Disclosure and Conflicts of Interest. All authors must disclose 
any current or former relationships (eg, employment, consultancies, board 
membership, stock ownership, funding, honoraria, expert testimony, patents or 
royalties, travel reimbursements, industry-supplied free reagents, etc) with any 
organization or entity having a direct financial or personal interest in the subject 
matter or materials discussed in the article. Authors should err on the side of full 
disclosure and should contact the Editorial Office if they have questions or 
concerns. This information should be provided at the time of submission and 
reiterated as part of copyright assignment. Failure to do so may result in 
manuscript rejection or editorial retraction of the article. Further information can be 
found in the Journal Scientific Integrity Policy at http://www.journals.elsevierhealth.
com/periodicals/ajpa/content/integrity. Upon manuscript acceptance, all coauthors 
will be instructed to formally disclose all potential conflicts.  
 
Publication Charges 
 Figure and Table Charges: Authors will be charged $550 per color figure, $50 
per black & white or grayscale figure, and $50 per composed table, per printed 
page (ie, figures or tables necessitating more than one printed page will incur an 
additional charge). Corresponding authors of published manuscripts who are 
current, dues-paying regular members of ASIP at the time of submission will 
receive one free color figure as a benefit of membership; page charges will not be 
waived for ASIP members.  
 
 Page Charges: Authors will be charged $95 per printed page. Manuscripts arising 
from research in developing countries may be eligible for waiver of publication 
charges only if all authors are located in a qualifying country (for a list of eligible 
countries, see Group A and Group B countries at http://www.who.int/hinari/
eligibility/en). Otherwise, page charges will not be waived, except for solicited 
editorials.  
 
 Approval of Fees and Invoicing: A summary of publication charges (figures, 
tables, and supplemental data) will be presented to the corresponding author of 
accepted manuscripts for approval prior to publication; final page charges cannot 
be determined until final publication. Color figure charges will not be waived, but 
color figures may be published in black and white, pending editorial approval. 
Requests for black and white figure publication must be made prior to execution of 
the publication charge approval form to avoid color charges. A final invoice will be 
presented immediately after publication; full payment is expected at that time. 
Failure to pay publication charges may result in the authors’ inability to publish 
future articles in The American Journal of Pathology.  
 
Open Choice. In addition to publication charges outlined above, authors may 
elect to participate in the Journal’s Open Choice program. Articles published under 
Open Choice will become immediately accessible on the Journal website upon 
publication, without the twelve-month subscriber-only access delay. Authors 
wishing to participate should contact the Editorial Office following manuscript 
acceptance. All copyright restrictions regarding reuse still apply. Cost to participate 
is $1500, which must be received before article restriction is lifted. 
 
Reprints. Reprints should be ordered when page proofs are returned; an order 
form is included with the proofs. Late reprint orders may result in additional fees. 
Author reprints will be supplied in CMYK color mode because it is a printed 
medium, but electronic reprints will be supplied in RGB color mode for visualization 
on screen. There is no extra charge for color reprints. Each coauthor will receive 
one complimentary electronic (secure PDF) reprint. Additional electronic reprints  
can be ordered at the time page proofs are returned or at a later date. No hardcopy 
complimentary reprints are provided by the publisher. 
 
Proofs. The corresponding author will be contacted by email once proofs are 
ready, and will be directed to download electronic proofs from a secure website. 
Electronic page proofs will be provided in RGB, thus reflecting the online quality. 
Image files will be converted to CMYK for the printed journal; all images published 
online will be in RGB. Full instructions on completing proof corrections will be 
provided with the downloaded proof. The author should check the proofs carefully, 
mark any printer's errors, and answer queries as requested. Author changes 
should be kept to a minimum. Proof corrections and replacement figures (if any) 
must be returned within 48 hours to avoid any delay in publication.  
 
Cover Figure. The cover figure is selected by the Editors from illustrations 
appearing in the current issue. Authors are encouraged to suggest a figure for 
consideration or include an additional cover figure submission along with their  
manuscript submission. Cover figures are published at no charge; cover reprints 
are available as cover stock reprints or posters (no complimentary cover reprints 
are provided by the publisher). 
 
Editorial Communications. All correspondence concerning editorial matters 
should be addressed to the Editor-in-Chief at The American Journal of Pathology,  
9650 Rockville Pike, Bethesda, Maryland, USA 20814-3993, faxed to 301-634-
7961, or emailed to ajp@asip.org. Appeals (rebuttals) to editorial decisions must 
be submitted within 60 days to be considered. Letters to the Editor will be printed at 
the Editors' discretion in the Correspondence section.  
 
Corrections are published upon request and after editorial review. Retractions 
are published upon request of authors or their institutions and may also be 
published by the Journal following a determination of scientific misconduct. Notes
of Concern are published in response to editorial concerns relating to scientific or 
publishing misconduct by authors or reviewers or to alert the scientific community 
of an ongoing investigation. 
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